Upper Urinary Tract Calculi
Conditions
Interventions
Research group (2 weeks):A string-attached ureteral stent was indwelled postoperatively and removed two weeks after surgery.
control group(4 weeks):A conventional ureteral stent is indwelled postoperatively and removed via cystoscopy four weeks after surgery.
control group(2 weeks):A conventional ureteral stent is indwelled postoperatively and removed via cystoscopy two weeks after surgery.
Research group (4 weeks):A string-attached ureteral stent was indwelled postoperatively and removed four weeks after surgery.
Sponsors
The Fifth Affiliated Hospital Sun Yat sen University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Patients who have voluntarily signed the informed consent form. 2.Patients aged over 18 years old with full capacity for civil conduct. 3.Patients who have been standardly diagnosed with upper urinary tract calculi (including ureteral calculi and/or renal calculi) in accordance with the Guidelines for the Diagnosis and Treatment of Urological and Andrological Diseases in China, and are scheduled to undergo ureteroscopic lithotripsy or flexible ureteroscopic lithotripsy.
Exclusion criteria
Exclusion criteria: 1. Patients with uncontrolled urinary tract infections (UTIs) who meet the following criteria: (1) Patients with urinary tract symptoms: Clean-catch midstream urine culture: colony count >= 10^5 CFU/mL (single pathogenic bacterium); OR centrifuged sediment of clean-catch midstream urine: leukocyte esterase (+) or urine leukocyte count >= 10 cells/HPF (high-power field), plus urine culture colony count >= 10^3 CFU/mL (single pathogenic bacterium). (2) Patients without urinary tract symptoms: Two consecutive clean-catch midstream urine cultures showing the same single pathogenic bacterium, with colony count >= 10^5 CFU/mL in both tests. 2. Patients with absolute contraindications to ureteroscopic/flexible ureteroscopic surgery. 3. Patients who are unable to understand or cooperate with the conduct of the trial. 4. Patients requiring percutaneous nephrolithotomy (PCNL). 5. Patients who need long-term indwelling ureteral stents for more than 4 weeks and 2 days after surgery. 6. Patients with any other conditions that the investigators believe may increase risks to the participants or interfere with the clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative urinary tract infection rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| complete blood count(white blood cell count etc.);Ureteral stent symptom ;Adverse event rate; Overactive Bladder Symptom Score (OABSS);Lower urinary tract symptoms;visual analogue scale;Procalcitonin; | — |
Countries
China
Contacts
Public ContactYinghao Yin
The Fifth Affiliated Hospital Sun Yat sen University
Outcome results
None listed